Remove Aortic Remove Embolism Remove Strokes
article thumbnail

Acute type A aortic dissection with cerebral malperfusion: diagnosis and repair using a novel technique

The British Journal of Cardiology

Though a rare condition, acute type A aortic dissection (ATAAD) is associated with high morbidity and mortality; hence, timely diagnosis and surgery are important to reduce the risk of mortality. If the dissection extends into the aortic arch branches, ensuring adequate cerebral perfusion during surgery is crucial to preventing stroke.

Aortic 40
article thumbnail

Brain-Protected TAVR Results in Fewer Real-World Disabling Strokes

Med Page Today

(MedPage Today) -- NEW YORK CITY -- Researchers eked out evidence of a small clinical benefit with the Sentinel cerebral embolic protection (CEP) device in transcatheter aortic valve replacement (TAVR) -- and pointed to the patients more likely.

TAVR 105
article thumbnail

Cerebral Embolic Protection for TAVI Doesn't Cut Strokes, Trial Affirms

Med Page Today

(MedPage Today) -- CHICAGO -- Routine use of devices to prevent cerebral emboli during transcatheter aortic valve implantation (TAVI) did not prevent strokes, a large randomized trial showed. Incidence of stroke within 72 hours after TAVI or.

article thumbnail

The efficacy of different types of cerebral embolic protection device during transcatheter aortic valve implantation: a meta-analysis

Frontiers in Cardiovascular Medicine

Aims Perioperative stroke remains a devastating complication after transcatheter aortic valve implantation (TAVI), and using a cerebral embolic protection device (CEPD) during TAVI may reduce the occurrence of stroke according to some studies. The risk of stroke was lower in the CEPD group: RR 0.68, 95% CI 0.49–0.96,

article thumbnail

Stroke reduction by cerebral embolic protection devices in transcatheter aortic valve implantation: a systematic review and Bayesian meta-analysis

Heart BMJ

Objectives The use of cerebral embolic protection (CEP) during transcatheter aortic valve implantation (TAVI) has been studied in several randomised trials. We aimed to perform a systematic review and Bayesian meta-analysis of randomised CEP trials, focusing on a clinically relevant reduction in disabling stroke.

article thumbnail

Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement

American College of Cardiology

The goal of the PROTECTED TAVR trial was to evaluate the efficacy of intraprocedural cerebral embolic protection (CEP) in reducing strokes among patients undergoing transfemoral TAVR for aortic stenosis.

article thumbnail

Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Implantation: Meta‐Analysis With Trial Sequential Analysis

Journal of the American Heart Association

BackgroundWe aimed to reevaluate randomized controlled trial data on outcomes of cerebral embolic protection device use during transcatheter aortic valve implantation. Primary outcomes included all stroke, disabling stroke, and allcause mortality.